Impact of human T cell leukemia virus type 1 in living donor liver transplantation

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1479-1485

  Yoshizumi, T ^a   Shirabe, K ^a   Ikegami, T ^a   Kayashima, H ^a   Yamashita, N ^b   Morita, K ^a   Masuda, T ^a   Hashimoto, N ^a   Taketomi, A ^a   Soejima, Y ^a   Maehara, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

ATL; HTLV 1; living donor liver transplantation

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; T CELL LEUKEMIA;

ADULT; AGED; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 84861804634     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04037.x     Document Type: Article

References (22)

1. Höllsberg P, Hafler DA,. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993; 328: 1173-1182.
2. Soyama A, Eguchi S, Takatsuki M, et al,. Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. Liver Transpl 2008; 14: 647-650.
3. Sonoda S, Li HC, Tajima K,. Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal. Cancer Sci 2011; 102: 295-301.
4. Hoshida Y, Li T, Dong Z, et al,. 2288; Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001; 91: 869-875.
5. González-Pérez MP, Muñoz-Juárez L, Cárdenas FC, Zarranz Imirizaldu JJ, Carranceja JC, García-Saiz A,. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation 2003; 75: 1006-1011.
6. Tanabe K, Kitani R, Takahashi K, et al,. Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 1998; 30: 3168-3170.
7. Kawano N, Shimoda K, Ishikawa F, et al,. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006; 82: 840-843.
8. Yoshizumi T, Taketomi A, Uchiyama H, et al,. Graft size, donor age, and patient status are the indicators of early graft function after living donor liver transplantation. Liver Transpl 2008; 14: 1007-1013.
9. Yoshizumi T, Taketomi A, Soejima Y, et al,. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int 2008; 21: 833-842.
10. Yoshizumi T, Shirabe K, Soejima Y, et al,. Living donor liver transplantation in patients older than 60 years. Transplantation 2010; 90: 433-437.
11. Soejima Y, Taketomi A, Ikegami T, et al,. Living donor liver transplantation using dual grafts from two donors: A feasible option to overcome small-for-size graft problems? Am J Transplant 2008; 8: 887-892.
12. Kuramitsu K, Gallo D, Yoon M, et al,. Carbon monoxide enhances early liver regeneration in mice after hepatectomy. Hepatology 2011; 53: 2016-2026.
13. Zou Y, Chen T, Han M, et al,. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol 2010; 184: 466-475.
14. Stewart SA, Feuer G, Jewett A, Lee FV, Bonavida B, Chen IS,. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice. Virology 1996; 226: 167-175.
15. Seki S, Habu Y, Kawamura T, et al,. The liver as a crucial organ in the first line of host defense: The roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev 2000; 174: 35-46.
16. Marvin MR, Brock GN, Kwarteng K, et al,. Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: Is it safe? Transplantation 2009; 87: 1180-1190.
17. Nakamizo A, Akagi Y, Amano T, et al,. Donor-derived adult T-cell leukaemia. Lancet 2011; 377: 1124.
18. Silva MT, Harab RC, Leite AC, Schor D, Araújo A, Andrada-Serpa MJ,. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection. Clin Infect Dis 2007; 44: 689-692.
19. HIV transmitted from a living organ donor-New York City, 2009. Am J Transplant 2011; 11: 1334-1337.
20. Haynes RA 2nd, Ware E, Premanandan C, et al,. Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model. Blood 2010; 115: 815-823.
21. Goedert JJ, Li HC, Gao XJ, et al,. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer 2007; 121: 1092-1097.
22. Kannagi M, Hasegawa A, Kinpara S, Shimizu Y, Takamori A, Utsunomiya A,. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity. Cancer Sci 2011; 102: 670-676.